JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hendershot, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hendershot, L. C.
Journal of Pharmacology And Experimental Therapeutics, Vol. 123, Issue 1, 1-8, 1958
Copyright © 1958 by American Society for Pharmacology and Experimental Therapeutics


CARDIOVASCULAR ACTIONS OF A BIS-ISOTHIOUREA

Leland C. Hendershot 1

1 Biochemical Research Laboratory, The Dow Chemical Company, Midland, Michigan

Prolonged hypotension occurs after the intravenous administration of 2, 2'-oxybis (p-phenylenemethylene) bis-isothiourea (BITU). Brief hypertension precedes the hypotension.

The hypertension is accompanied by reflex vasoconstriction and the hypotension by brief reflex vasodilatation in the perfused hind limb of of the dog. Reflex vasoconstriction is probably due to ganglionic effects; reflex vasodilatation is due, at least in part, to an action in the head. A more persistent vasodilator action is also seen and is attributed to a direct effect on the vasculature.

Cardiac output is not reduced in the dog heartlung preparation by large doses of BITU but responses to increased right atrial pressure are impaired. In the intact animal, the electrocardiogram remains normal until just before death.

BITU potentiates the actions of norepinephrine and DMP (P1, 1'-dimethyl-4-phenylpiperazinium).

A rise in plasma histamine levels was not detected in dogs or cats which had received doses of BITU large enough to cause marked hypotension. Following lethal or near lethal doses, plasma levels of histamine were increased.

Submitted on January 17, 1958




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. P. Garvey, J. A. Oplinger, E. S. Furfine, R. J. Kiff, F. Laszlo, B. J.R. Whittle, and R. G. Knowles
1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo
J. Biol. Chem., February 21, 1997; 272(8): 4959 - 4963.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1958 by the American Society for Pharmacology and Experimental Therapeutics.